Variant ID: 8-6368412-T-C

NM_001147.2(ANGPT2):c.1200-1829A>G

This variant was identified in 1 publication




Publications:


Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Plos One
I Makhoul, VK Todorova, ER Siegel, SW Erickson, I Dhakal, VR Raj, JY Lee, MS Orloff, RJ Griffin, RS Henry-Tillman, S Klimberg, LF Hutchins, SA Kadlubar
Publication Date: 2017

Variant appearance in text: rs2442632
PubMed Link: 28045923
PubMed Central Link
Variant Present in the following documents:
  • pone.0168550.s006.xlsx
  • pone.0168550.s005.xlsx
  • pone.0168550.s007.xlsx
View BVdb publication page



Alternative transcript annotations:

Transcript cDNA Protein Consequence Exon Intron
ENST00000325203.5 c.1200-1829A>G - intron_variant - 7/8
ENST00000338312.6 c.1044-1829A>G - intron_variant - 6/7
ENST00000344683.5 c.2214+10962T>C - intron_variant - 12/13
ENST00000415216.1 c.1197-1829A>G - intron_variant - 7/8
ENST00000519221.1 n.321+10962T>C - intron_variant,non_coding_transcript_variant - 4/4
ENST00000521129.1 n.372+10962T>C - intron_variant,non_coding_transcript_variant - 4/4
ENST00000523120.1 c.1197-1829A>G - intron_variant - 7/7
NM_001118887.2 c.1197-1829A>G - intron_variant - 7/8
NM_001118888.2 c.1044-1829A>G - intron_variant - 6/7
NM_001147.3 c.1200-1829A>G - intron_variant - 7/8
NM_001322042.2 c.2214+10962T>C - intron_variant - 12/14
NM_001363979.1 c.2214+10962T>C - intron_variant - 12/13
NM_001363980.2 c.1935+55639T>C - intron_variant - 9/10
NM_024596.5 c.2214+10962T>C - intron_variant - 12/13